Jiangsu Hengrui reported CNY3.47B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Sh Fosun Pharma CNY 36.02B 522.8M Jun/2025
Sh Pharmaceutical CNY 140.13B 9.32B Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Wuxi Apptec CNY 20.52B 1.65B Jun/2025
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025